A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 19
- Registration Number
- NCT00410358
- Locations
- 🇯🇵
Novartis Investigative Site, Chiba Prefecture, Japan
Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2006-12-08
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Registration Number
- NCT00409019
Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients
- Conditions
- Liver Transplantation
- Interventions
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2011-03-03
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 34
- Registration Number
- NCT00405652
- Locations
- 🇩🇪
Novartis Investigative Site, Nuernberg, Germany
Dose Ranging Study for Indacaterol in Japanese Asthma Patients
- First Posted Date
- 2006-11-27
- Last Posted Date
- 2011-08-17
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 41
- Registration Number
- NCT00403754
- Locations
- 🇯🇵
Novartis, Tokyo, Japan
🇯🇵Novartis Investigator Site, Yokohama, Japan
🇯🇵Novartis Investigative Site, Tokyo, Japan
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 215
- Registration Number
- NCT00403416
- Locations
- 🇨🇭
Inselspital Bern, Bern, Switzerland
🇮🇹Azienda Ospedaliera di Padova - Universita degli Studi, Padova, Italy
🇺🇸University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT00402909
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance
- Conditions
- Renal Transplantation
- Interventions
- First Posted Date
- 2006-11-16
- Last Posted Date
- 2011-08-15
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 400
- Registration Number
- NCT00400400
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis
- First Posted Date
- 2006-11-07
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 128
- Registration Number
- NCT00396409
- Locations
- 🇩🇪
Novartis Investigator site, Nuremberg, Germany
Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-11-06
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 2665
- Registration Number
- NCT00396227
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
- First Posted Date
- 2006-11-06
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 914
- Registration Number
- NCT00396357
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
🇩🇪Novartis Investigative Site, Multiple Locations, Germany